The induction of anterior chamber-associated immune deviation
- PMID: 17264480
- DOI: 10.1159/000099251
The induction of anterior chamber-associated immune deviation
Abstract
Evidence of ocular immune privilege was noted almost 130 years ago. The past 30 years have witnessed an explosion in research on ocular immune privilege. One of the primary mechanisms that contribute to ocular immune privilege is the unique form of immune deviation that is invoked when antigens are introduced into the anterior chamber (AC) of the eye - a phenomenon termed AC-associated immune deviation (ACAID). ACAID embodies a constellation of cellular interactions and at least four different organ systems: eye, thymus, spleen, and sympathetic nervous system. At least four different cell populations interact to generate CD8+ T regulatory cells that suppress both Th1- and Th2-mediated inflammation. The interactions that occur between F4/80+ antigen-presenting cells, CD4+ T regulatory cells, NK1.1+ T cells, gammadelta T cells, B cells, and CD8+ T cells remain to be fully elucidated. Ocular immune privilege was originally perceived as a simple anatomic anomaly that has evolved to be one of the most sophisticated and intriguing forms of immune regulation.
Similar articles
-
Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10.J Immunol. 2006 Dec 15;177(12):8331-7. doi: 10.4049/jimmunol.177.12.8331. J Immunol. 2006. PMID: 17142729
-
Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.J Immunol. 2001 Jan 1;166(1):26-32. doi: 10.4049/jimmunol.166.1.26. J Immunol. 2001. PMID: 11123273
-
Role of splenic B cells in the immune privilege of the anterior chamber of the eye.Eur J Immunol. 1995 Oct;25(10):2783-7. doi: 10.1002/eji.1830251011. Eur J Immunol. 1995. PMID: 7589072
-
Therapies based on principles of ocular immune privilege.Chem Immunol Allergy. 2007;92:317-327. doi: 10.1159/000099281. Chem Immunol Allergy. 2007. PMID: 17264506 Review.
-
Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.Eye (Lond). 1995;9 ( Pt 2):236-40. doi: 10.1038/eye.1995.46. Eye (Lond). 1995. PMID: 7556724 Review.
Cited by
-
Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium.Int J Mol Sci. 2016 Mar 22;17(3):415. doi: 10.3390/ijms17030415. Int J Mol Sci. 2016. PMID: 27102165 Free PMC article.
-
Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.Clin Exp Immunol. 2014 Apr;176(1):37-48. doi: 10.1111/cei.12243. Clin Exp Immunol. 2014. PMID: 24266626 Free PMC article.
-
Perspectives and Limitations of Mesenchymal Stem Cell-Based Therapy for Corneal Injuries and Retinal Diseases.Cell Transplant. 2025 Jan-Dec;34:9636897241312798. doi: 10.1177/09636897241312798. Cell Transplant. 2025. PMID: 39856809 Free PMC article. Review.
-
Eye-mediated induction of specific immune tolerance to encephalitogenic antigens.CNS Neurosci Ther. 2013 Jul;19(7):503-10. doi: 10.1111/cns.12087. Epub 2013 Mar 22. CNS Neurosci Ther. 2013. PMID: 23522052 Free PMC article.
-
Type II Collagen-Specific B Cells Induce Immune Tolerance in Th1-Skewed, Th2-Skewed, and Arthritis-Prone Strains of Mice.Cells. 2021 Apr 12;10(4):870. doi: 10.3390/cells10040870. Cells. 2021. PMID: 33921248 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous